SEARCH

SEARCH BY CITATION

References

  • 1
    Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:24465.
  • 2
    Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007;370:890907.
  • 3
    Gustafsson L, Ponten J, Zack M, Adami HO. International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 1997;8:75563.
  • 4
    Reid R. Biology and colposcopic features of human papillomavirus-associated cervical disease. Obstet Gynecol Clin North Am 1993;20:12351.
  • 5
    Jeronimo J, Massad LS, Schiffman M. Visual appearance of the uterine cervix: correlation with human papillomavirus detection and type. Am J Obstet Gynecol 2007;197:478.
  • 6
    Louwers JA, Kocken M, van der Bijl JC, Berkhof J, Snijders PJ, Meijer CJ, et al. Colposcopic characteristics of high-risk human papillomavirus-related cervical lesions. J. Low. Genit. Tract Dis. 2010;14:4955.
  • 7
    Petry KU, Luyten A, Scherbring S. Accuracy of colposcopy management to detect CIN3 and invasive cancer in women with abnormal screening tests: results from a primary HPV screening project from 2006 to 2011 in Wolfsburg, Germany. Gynecol Oncol 2013;128:2827.
  • 8
    Reid R, Herschman BR, Crum CP, Fu YS, Braun L, Shah KV, et al. Genital warts and cervical cancer. V. The tissue basis of colposcopic change. Am J Obstet Gynecol 1984;149:293303.
  • 9
    Mitchell MF, Schottenfeld D, Tortolero-Luna G, Cantor SB, Richards-Kortum R. Colposcopy for the diagnosis of squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1998;91:62631.
  • 10
    Bekkers RL, van de Nieuwenhof HP, Neesham DE, Hendriks JH, Tan J, Quinn MA. Does experience in colposcopy improve identification of high grade abnormalities? Eur J Obstet Gynecol Reprod Biol 2008;141:758.
  • 11
    Schiffman M, Solomon D. Findings to date from the ASCUS-LSIL Triage Study (ALTS). Arch Pathol Lab Med 2003;127:9469.
  • 12
    Massad LS, Jeronimo J, Katki HA, Schiffman M. The accuracy of colposcopic grading for detection of high-grade cervical intraepithelial neoplasia. J. Low. Genit. Tract Dis. 2009;13:13744.
  • 13
    Wentzensen N, Schiffman M, Dunn ST, Zuna RE, Walker J, Allen RA, et al. Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma. Int J Cancer 2009;124:9649.
  • 14
    Gage JC, Hanson VW, Abbey K, Dippery S, Gardner S, Kubota J, et al. Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol 2006;108:26472.
  • 15
    Pretorius RG, Zhang WH, Belinson JL, Huang MN, Wu LY, Zhang X, et al. Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol 2004;191:4304.
  • 16
    Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El GF. Carcino-genicity of human papillomaviruses. Lancet Oncol. 2005;6:204.
  • 17
    Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005;97:10729.
  • 18
    de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11:104856.
  • 19
    Tjalma WA, Fiander A, Reich O, Powell N, Nowakowski AM, Kirschner B, et al. Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. Int J Cancer 2013;132:85467.
  • 20
    Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J Natl Cancer Inst 2009;101:47587.
  • 21
    Porras C, Rodriguez AC, Hildesheim A, Herrero R, Gonzalez P, Wacholder S, et al. Human papillomavirus types by age in cervical cancer precursors: predominance of human papillomavirus 16 in young women. Cancer Epidemiol. Biomarkers Prev. 2009;18:8635.
  • 22
    Zaal A, Louwers JA, Berkhof J, Kocken M, Ter Harmsel WA, Graziosi GC, et al. Agreement between colposcopic impression and histological diagnosis among human papillomavirus type 16-positive women: a clinical trial using dynamic spectral imaging colposcopy. BJOG 2012;119:53744.
  • 23
    Cuschieri KS, Cubie HA, Whitley MW, Seagar AL, Arends MJ, Moore C, et al. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 2004;57:6872.
  • 24
    van der Marel J, Quint WG, Schiffman M, van de Sandt MM, Zuna RE, Dunn ST, et al. Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16. Int J Cancer 2012;131:E94653.
  • 25
    Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American cancer society, american society for colposcopy and cervical pathology, and american society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 2012;137:51642.
  • 26
    Bulk S, Van Kemenade FJ, Rozendaal L, Meijer CJ. The Dutch CISOE – A framework for cytology reporting increases efficacy of screening upon standardisation since 1996. J Clin Pathol 2004;57:38893.
  • 27
    Reid R, Scalzi P. Genital warts and cervical cancer. VII. An improved colposcopic index for differentiating benign papillomaviral infections from high-grade cervical intraepithelial neoplasia. Am J Obstet Gynecol 1985;153:6118.
  • 28
    Geraets DT, Heideman DA, de Koning MN, Snijders PJ, van Alewijk DC, Meijer CJ, et al. High-throughput genotyping of high-risk HPV by the digene HPV Genotyping LQ Test using GP5+/6+-PCR and xMAP technology. J Clin Virol 2009;46(Suppl 3):S216.
  • 29
    Quint W, Jenkins D, Molijn A, Struijk L, van de Sandt M, Doorbar J, et al. One virus one lesion –individual components of CIN lesions contain a specific HPV type. J Pathol. 2011;227:6271.
  • 30
    Bekkers RL, Melchers WJ, Bulten J, Boonstra H, Quint WG, Hanselaar AG, et al. Localized distribution of human papillomavirus genotypes in the uterine cervix. Eur J Gynaecol Oncol 2002;23:2036.
  • 31
    Wentzensen N, Walker J, Schiffman M, Yang HP, Zuna RE, Dunn ST, et al. Heterogeneity of high grade cervical intraepithelial neoplasia related to HPV16: implications for natural history and management. Int J Cancer 2012;132:14854.
  • 32
    Tidy JA, Brown BH, Healey TJ, Daayana S, Martin M, Prendiville W, et al. Accuracy of detection of high-grade cervical intraepithelial neoplasia using electrical impedance spectroscopy with colposcopy. BJOG 2013;120:40010; discussion 10-1.
  • 33
    Geraets DT, Heideman DA, de Koning MN, Snijders PJ, Meijer CJ, van Doorn LJ, et al. High genotyping concordance between the digene HPV Genotyping RH Test and the Reverse Line Blot genotyping assay on GP5+/6+-PCR products. J Clin Virol 2009;46(Suppl 3):S1620.
  • 34
    McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 2008;9:42534.
  • 35
    Leeson SC, Alibegashvili T, Arbyn M, Bergeron C, Carriero C, Mergui JL, et al. The future role for colposcopy in Europe. J. Low. Genit. Tract Dis. 2014;18:708.